At a glance
- Originator Nonindustrial source
- Class Antiandrogens; Antineoplastics
- Mechanism of Action Cholestenone 5-alpha reductase inhibitors; Steroid 17-alpha-hydroxylase inhibitors; Testosterone congener inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Prostate cancer